PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Wright Center for Clinical and Translational Research, Virginia Commonwealth University, Richmond, VA, United States.\', \'First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, Genoa, Italy.\', \'Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, United States.\', \'Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA, United States.\', \'Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, United States.\', \'Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH, United States.\', \'Respiratory Institute, Cleveland Clinic, Clevaland, OH, United States.\', \'Division of Pulmonary, Critical Care and Sleep Medicine, University of Cincinnati, Cincinnati, OH, United States.\', \'Division of Pulmonary Biology, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH, United States.\', \'Academic Regulatory & Monitoring Services, LLC, Cincinnati, OH, United States.\', \'Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2020.01625
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 32719685
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all